Have you completed any training to prepare for offering psilocybin treatment in the event that it eventually becomes FDA-approved for difficult-to-treat depression?

It seems that places that offer TMS and ketamine will be the ones to adopt it, as they already have the infrastructure for it. I don't see generalists using it that much.

This is a great question, as it raises the issue of how applicable the modality will be for a typical private practice outpatient setting. One of the issues with using psilocybin in a private setting is the duration of effect (around 4-6 hrs) of the drug, and therefore the required monitoring time o...